Get started
Innovent Biologics Inc.Innovent Biologics Inc.Innovent Biologics Inc.

Innovent Biologics Inc.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪18.93 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
126.36
Basic EPS (TTM)
0.09 USD
Net income (FY)
‪−13.20 M‬ USD
Revenue (FY)
‪1.31 B‬ USD
Shares float
‪1.54 B‬
Beta (1Y)
0.64

Employees


Employees (FY)
‪5.66 K‬
Change (1Y)
+787 +16.15%
Revenue / Employee (1Y)
‪232.29 K‬ USD
Net income / Employee (1Y)
‪−2.33 K‬ USD

About Innovent Biologics, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
De Chao Yu
Website
innoventbio.com
Headquarters
Suzhou
Founded
2011
ISIN
KYG4818G1010
FIGI
BBG00PDF9N51
Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. It operates through the following geographical segments: The People's Republic of China (PRC), the United States of America (USA), and Indonesia. The company was founded by De Chao Yu, Kevin Chen, and Scott M. Wheelwright on April 28, 2011 and is headquartered in Suzhou, China.

Check out other big names from the same industry as IVBXF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs


VXUS
Vanguard Total International Stock ETF
Weight
0.05%
Market value
‪259.73 M‬
USD
VWO
Vanguard FTSE Emerging Markets ETF
Weight
0.16%
Market value
‪238.97 M‬
USD
513120
GF CSI Hong Kong Brand Name Drug Exchange Traded Fund Units
Weight
9.57%
Market value
‪181.73 M‬
USD
IEMG
iShares Core MSCI Emerging Markets ETF
Weight
0.15%
Market value
‪175.00 M‬
USD
159570
China Universal CNI HK Connect Innovative Drug ETF
Weight
9.35%
Market value
‪105.97 M‬
USD
3432
CSOP ETF Series - CSOP MSCI HK China Connect Select ETF Units
Weight
5.68%
Market value
‪88.54 M‬
USD
159636
ICBC Credit Suisse CNI HK Connect Technology ETF
Weight
2.59%
Market value
‪82.98 M‬
USD
159892
ChinaAMC Hang Seng Hong Kong-Listed Biotech Index ETF Units A
Weight
10.27%
Market value
‪65.22 M‬
USD
513980
INVESCO Great Wall CSI Hong Kong Connect Technology Index Exchange Traded Fund Units
Weight
3.08%
Market value
‪63.33 M‬
USD
EIMU
iShares Core MSCI EM IMI UCITS ETF
Weight
0.15%
Market value
‪49.15 M‬
USD
EIMI
iShares Core MSCI EM IMI UCITS ETF
Weight
0.15%
Market value
‪49.15 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of IVBXF is 11.16 USD — it has decreased by −5.34% in the past 24 hours. Watch Innovent Biologics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Innovent Biologics Inc. stocks are traded under the ticker IVBXF.
IVBXF stock has fallen by −8.00% compared to the previous week, the month change is a 2.24% rise, over the last year Innovent Biologics Inc. has showed a 132.11% increase.
We've gathered analysts' opinions on Innovent Biologics Inc. future price: according to them, IVBXF price has a max estimate of 17.78 USD and a min estimate of 12.85 USD. Watch IVBXF chart and read a more detailed Innovent Biologics Inc. stock forecast: see what analysts think of Innovent Biologics Inc. and suggest that you do with its stocks.
IVBXF reached its all-time high on Sep 2, 2025 with the price of 15.12 USD, and its all-time low was 2.29 USD and was reached on May 13, 2022. View more price dynamics on IVBXF chart.
See other stocks reaching their highest and lowest prices.
IVBXF stock is 5.65% volatile and has beta coefficient of 0.64. Track Innovent Biologics Inc. stock price on the chart and check out the list of the most volatile stocks — is Innovent Biologics Inc. there?
Today Innovent Biologics Inc. has the market capitalization of ‪18.85 B‬, it has increased by 2.23% over the last week.
Yes, you can track Innovent Biologics Inc. financials in yearly and quarterly reports right on TradingView.
Innovent Biologics Inc. is going to release the next earnings report on Apr 1, 2026. Keep track of upcoming events with our Earnings Calendar.
IVBXF earnings for the last half-year are 0.07 USD per share, whereas the estimation was 0.03 USD, resulting in a 183.33% surprise. The estimated earnings for the next half-year are 0.01 USD per share. See more details about Innovent Biologics Inc. earnings.
Innovent Biologics Inc. revenue for the last half-year amounts to ‪730.37 M‬ USD, despite the estimated figure of ‪790.35 M‬ USD. In the next half-year revenue is expected to reach ‪933.66 M‬ USD.
IVBXF net income for the last half-year is ‪114.13 M‬ USD, while the previous report showed ‪41.60 M‬ USD of net income which accounts for 174.37% change. Track more Innovent Biologics Inc. financial stats to get the full picture.
No, IVBXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 9, 2025, the company has ‪5.66 K‬ employees. See our rating of the largest employees — is Innovent Biologics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Innovent Biologics Inc. EBITDA is ‪308.76 M‬ USD, and current EBITDA margin is 6.00%. See more stats in Innovent Biologics Inc. financial statements.
Like other stocks, IVBXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Innovent Biologics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Innovent Biologics Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Innovent Biologics Inc. stock shows the buy signal. See more of Innovent Biologics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.